Stampacchia Otello
CIK 0001361712
Director10% Owner
Filings
7
Latest Jul 30, 2025
Issuers covered
4
Showing
7 of 7
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 17% | -7.7% | -12.3% | +24.3% | -18.2% |
| 90 days | 6 | 83% | +5.5% | +7.2% | +61.6% | -56.9% |
| 180 days | 6 | 17% | -18.3% | -19.3% | +26.3% | -58.6% |
| 365 days | 5 | 0% | -24.3% | -23.6% | -21.6% | -28.0% |
Issuers
Companies where Stampacchia Otello has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IKNA | Ikena Oncology, Inc. | 4 | Jul 30, 2025 |
| KRON | Kronos Bio, Inc. | 1 | Jun 29, 2022 |
| LXEO | Lexeo Therapeutics, Inc. | 1 | Nov 9, 2023 |
| REPL | Replimune Group, Inc. | 1 | Mar 16, 2022 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|